Merozoite vaccination against Plasmodium knowlesi malaria

Area of Science:

• Parasitology
• Immunology
• Tropical Medicine

Background:

• Plasmodium knowlesi causes uniformly lethal infections in Rhesus monkeys.
• Previous immunization methods and drug-controlled infections have limitations in inducing broad immunity.

Purpose of the Study:

• To evaluate the efficacy of merozoite vaccination against P. knowlesi infection in Rhesus monkeys.
• To assess the degree and variant specificity of induced immunity.

Main Methods:

• Rhesus monkeys were vaccinated with P. knowlesi merozoites emulsified with Freund's complete (FCA) or incomplete (FIA) adjuvant.
• Vaccinated monkeys were challenged with homologous and heterologous P. knowlesi variants, and some with P. cynomolgi bastianellii.

Main Results:

• Vaccination induced protection against homologous P. knowlesi challenge, with some monkeys showing no parasitaemia and others low-grade infections.
• Multiple vaccinations with merozoites in FCA provided protection against distinct P. knowlesi variants.
• Monkeys developed chronic malaria when challenged with P. cynomolgi bastianellii, indicating species-specific immunity.

Conclusions:

• Merozoite vaccination in Rhesus monkeys confers substantial immunity against erythrocyte stages of P. knowlesi.
• This vaccination strategy demonstrates superior protection and broader variant specificity than previous methods.
• The findings highlight the potential of merozoite vaccines for controlling P. knowlesi malaria.